Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
BRZE Stock Summary
Top 10 Correlated ETFs
BRZE
In the News
BRZE Financial details
Company Rating
Sell
Market Cap
4.22B
Income
-129.54M
Revenue
471.8M
Book val./share
4.51
Cash/share
4.86
Dividend
-
Dividend %
-
Employees
1.55K
Optionable
No
Shortable
Yes
Earnings
06 Jun 2024
P/E
-36.19
Forward P/E
-
PEG
33.7
P/S
11.35
P/B
11.15
P/C
8.08
P/FCF
-1024.9
Quick Ratio
2.17
Current Ratio
2.28
Debt / Equity
0.2
LT Debt / Equity
0.17
-
-
EPS (TTM)
-1.33
EPS next Y
-
EPS next Q
-
EPS this Y
-11.41%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
30.41%
Revenue last 5Y
37.39%
Revenue Q/Q
5.65%
EPS Q/Q
-6.45%
-
-
-
-
SMA20
-20.34%
SMA50
-25.49%
SMA100
-17.34%
Inst Own
33.82%
Inst Trans
0.68%
ROA
-18%
ROE
-31%
ROC
-0.29%
Gross Margin
69%
Oper. Margin
-34%
Profit Margin
-31%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
25.76-61.53
52W High
-35.66%
52W Low
+57%
RSI
26.26
Rel Volume
0.85
Avg Volume
868.35K
Volume
735.78K
Perf Week
-9.71%
Perf Month
-27.18%
Perf Quarter
-8.01%
Perf Half Y
-16.44%
-
-
-
-
Beta
1.131
-
-
Volatility
1.38%, 5.1%
Prev Close
-0.71%
Price
39.25
Change
-2.61%
BRZE Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2024-01-31
Metric | History | 2020-01-31 | 2021-01-31 | 2022-01-31 | 2023-01-31 | 2024-01-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 1.06 | 1.63 | 2.56 | 3.76 | 4.81 | |
Net income per share | -0.35 | -0.35 | -0.84 | -1.49 | -1.32 | |
Operating cash flow per share | -0.08 | -0.07 | -0.38 | -0.24 | 0.07 | |
Free cash flow per share | -0.11 | -0.11 | -0.43 | -0.41 | -0.07 | |
Cash per share | 1.01 | 0.94 | 5.53 | 5.06 | 4.89 | |
Book value per share | -0.95 | -1.18 | 5.4 | 4.71 | 4.53 | |
Tangible book value per share | -0.95 | -1.15 | 5.43 | 4.72 | 4.2 | |
Share holders equity per share | -0.95 | -1.18 | 5.4 | 4.71 | 4.53 | |
Interest debt per share | 0.09 | 0.24 | 0 | 0.44 | 0.92 | |
Market cap | 8.5B | 8.6B | 4.65B | 3.03B | 5.3B | |
Enterprise value | 8.5B | 8.57B | 4.17B | 3.01B | 5.32B | |
P/E ratio | -267.33 | -269.08 | -59.49 | -21.5 | -41.05 | |
Price to sales ratio | 88.25 | 57.27 | 19.54 | 8.51 | 11.24 | |
POCF ratio | -1.15K | -1.41K | -131.37 | -135.66 | 774.03 | |
PFCF ratio | -857.31 | -824.59 | -116.92 | -77.57 | -817.59 | |
P/B Ratio | -97.88 | -79.28 | 9.27 | 6.8 | 11.94 | |
PTB ratio | -97.88 | -79.28 | 9.27 | 6.8 | 11.94 | |
EV to sales | 88.18 | 57.08 | 17.52 | 8.47 | 11.28 | |
Enterprise value over EBITDA | -258.36 | -290.65 | -55.19 | -20.96 | -38.8 | |
EV to operating cash flow | -1.15K | -1.41K | -117.84 | -134.88 | 776.8 | |
EV to free cash flow | -856.64 | -821.86 | -104.88 | -77.13 | -820.52 | |
Earnings yield | 0 | 0 | -0.02 | -0.05 | -0.02 | |
Free cash flow yield | 0 | 0 | -0.01 | -0.01 | 0 | |
Debt to equity | -0.1 | -0.2 | 0 | 0.12 | 0.2 | |
Debt to assets | 0.06 | 0.12 | 0 | 0.07 | 0.11 | |
Net debt to EBITDA | 0.2 | 0.97 | 6.34 | 0.12 | -0.14 | |
Current ratio | 1.98 | 1.32 | 3.8 | 2.68 | 2.08 | |
Interest coverage | 0 | -93.19 | -211.95 | 15.18 | 0 | |
Income quality | 0.23 | 0.19 | 0.45 | 0.16 | -0.05 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.17 | 0.19 | 0.22 | 0.25 | 0.22 | |
Research and developement to revenue | 0.21 | 0.19 | 0.25 | 0.27 | 0.25 | |
Intangibles to total assets | -0.06 | -0.06 | -0.02 | 0 | 0.04 | |
Capex to operating cash flow | 0.35 | 0.72 | 0.12 | 0.75 | -1.95 | |
Capex to revenue | -0.03 | -0.03 | -0.02 | -0.05 | -0.03 | |
Capex to depreciation | -3.96 | -2.74 | -1.58 | -3.62 | -1.92 | |
Stock based compensation to revenue | 0.13 | 0.05 | 0.2 | 0.2 | 0.21 | |
Graham number | 2.74 | 3.03 | 10.1 | 12.56 | 11.58 | |
ROIC | 0.43 | 0.38 | -0.16 | -0.27 | -0.24 | |
Return on tangible assets | -0.2 | -0.18 | -0.11 | -0.2 | -0.17 | |
Graham Net | -1.39 | -1.74 | 4.45 | 2.95 | 1.9 | |
Working capital | 62.71M | 32.83M | 448.22M | 365.87M | 311.68M | |
Tangible asset value | -77.77M | -95.27M | 519.27M | 446.26M | 412.29M | |
Net current asset value | -112.97M | -143.71M | 446.74M | 324.52M | 234.61M | |
Invested capital | -0.1 | -0.2 | 0 | 0.12 | 0.2 | |
Average receivables | 0 | 29.02M | 49.64M | 71.42M | 87.81M | |
Average payables | 0 | 825K | 1.26M | 2.59M | 4.71M | |
Average inventory | 0 | 8.98M | 17.4M | 12.45M | 0 | |
Days sales outstanding | 88.14 | 84.5 | 98.91 | 80.45 | 75.27 | |
Days payables outstanding | 12.39 | 2.94 | 9.68 | 9.77 | 15.64 | |
Days of inventory on hand | 82.39 | 66.33 | 115.76 | 0 | 0 | |
Receivables turnover | 4.14 | 4.32 | 3.69 | 4.54 | 4.85 | |
Payables turnover | 29.47 | 124.17 | 37.69 | 37.35 | 23.34 | |
Inventory turnover | 4.43 | 5.5 | 3.15 | 0 | 0 | |
ROE | 0.37 | 0.29 | -0.16 | -0.32 | -0.29 | |
Capex per share | -0.03 | -0.05 | -0.05 | -0.18 | -0.14 |
Quarterly Fundamentals Overview
Last date of statement is 2024-01-31 for Q4
Metric | History | 2023-01-31 | 2023-04-30 | 2023-07-31 | 2023-10-31 | 2024-01-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 1.04 | 1.06 | 1.18 | 1.27 | 1.33 | |
Net income per share | -0.36 | -0.4 | -0.33 | -0.31 | -0.29 | |
Operating cash flow per share | 0 | 0.23 | -0.18 | -0.02 | 0.04 | |
Free cash flow per share | -0.02 | 0.22 | -0.19 | -0.06 | -0.04 | |
Cash per share | 5.04 | 5.22 | 4.86 | 4.78 | 4.86 | |
Book value per share | 4.69 | 4.52 | 4.53 | 4.48 | 4.51 | |
Tangible book value per share | 4.7 | 4.53 | 4.21 | 4.16 | 4.18 | |
Share holders equity per share | 4.69 | 4.52 | 4.53 | 4.48 | 4.51 | |
Interest debt per share | 0.5 | 0.5 | 0.53 | 0.93 | 0.92 | |
Market cap | 3.04B | 2.83B | 4.42B | 4.17B | 5.33B | |
Enterprise value | 3.02B | 2.77B | 4.39B | 4.2B | 5.35B | |
P/E ratio | -22.47 | -18.25 | -34.85 | -33.89 | -47.1 | |
Price to sales ratio | 30.8 | 27.85 | 38.38 | 33.62 | 40.68 | |
POCF ratio | 253.24K | 125.71 | -252.2 | -2.08K | 1.39K | |
PFCF ratio | -1.58K | 130.89 | -236.35 | -705.08 | -1.51K | |
P/B Ratio | 6.82 | 6.51 | 10.03 | 9.51 | 11.99 | |
PTB ratio | 6.82 | 6.51 | 10.03 | 9.51 | 11.99 | |
EV to sales | 30.62 | 27.22 | 38.16 | 33.87 | 40.82 | |
Enterprise value over EBITDA | -86.76 | -68.62 | -149 | -127.62 | -184.09 | |
EV to operating cash flow | 251.8K | 122.85 | -250.73 | -2.1K | 1.4K | |
EV to free cash flow | -1.57K | 127.91 | -234.97 | -710.25 | -1.51K | |
Earnings yield | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | |
Free cash flow yield | 0 | 0.01 | 0 | 0 | 0 | |
Debt to equity | 0.12 | 0.12 | 0.12 | 0.21 | 0.2 | |
Debt to assets | 0.07 | 0.07 | 0.07 | 0.12 | 0.11 | |
Net debt to EBITDA | 0.5 | 1.6 | 0.87 | -0.93 | -0.65 | |
Current ratio | 2.68 | 2.44 | 2.31 | 2.28 | 2.08 | |
Interest coverage | 9.14 | 10.94 | 0 | 0 | 0 | |
Income quality | 0 | -0.58 | 0.55 | 0.06 | -0.14 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.23 | 0.31 | 0.27 | 0.21 | 0.2 | |
Research and developement to revenue | 0.27 | 0.29 | 0.25 | 0.24 | 0.24 | |
Intangibles to total assets | 0 | 0 | 0.04 | 0.04 | 0.04 | |
Capex to operating cash flow | -161.17 | -0.04 | 0.07 | 1.95 | -1.93 | |
Capex to revenue | -0.02 | -0.01 | -0.01 | -0.03 | -0.06 | |
Capex to depreciation | -1.14 | -0.58 | -0.89 | -1.75 | -3.91 | |
Stock based compensation to revenue | 0.19 | 0.24 | 0.22 | 0.19 | 0.19 | |
Graham number | 6.13 | 6.4 | 5.77 | 5.62 | 5.39 | |
ROIC | -0.07 | -0.08 | -0.07 | -0.06 | -0.05 | |
Return on tangible assets | -0.05 | -0.05 | -0.05 | -0.04 | -0.04 | |
Graham Net | 2.94 | 2.8 | 2.42 | 1.97 | 1.89 | |
Working capital | 365.87M | 353.07M | 325.57M | 318.41M | 311.68M | |
Tangible asset value | 446.26M | 436.23M | 408.93M | 406.71M | 412.29M | |
Net current asset value | 324.52M | 313.05M | 282.99M | 236.57M | 234.61M | |
Invested capital | 0.12 | 0.12 | 0.12 | 0.21 | 0.2 | |
Average receivables | 68.32M | 72.49M | 68.39M | 70.73M | 84.31M | |
Average payables | 2.58M | 3.34M | 2.73M | 3.91M | 6.13M | |
Average inventory | 9.76M | 1.69M | 3.37M | 3.37M | 1.69M | |
Days sales outstanding | 71.45 | 58.94 | 54.84 | 51.79 | 66.86 | |
Days payables outstanding | 8.35 | 9.83 | 4.77 | 14.71 | 13.23 | |
Days of inventory on hand | 0 | 9.29 | 8.56 | 8.35 | 0 | |
Receivables turnover | 1.26 | 1.53 | 1.64 | 1.74 | 1.35 | |
Payables turnover | 10.78 | 9.15 | 18.85 | 6.12 | 6.8 | |
Inventory turnover | 0 | 9.69 | 10.52 | 10.78 | 0 | |
ROE | -0.08 | -0.09 | -0.07 | -0.07 | -0.06 | |
Capex per share | -0.02 | -0.01 | -0.01 | -0.04 | -0.07 |
BRZE Frequently Asked Questions
What is Braze, Inc. stock symbol ?
Braze, Inc. is a US stock , located in New york of Ny and trading under the symbol BRZE
What is Braze, Inc. stock quote today ?
Braze, Inc. stock price is $39.25 today.
Is Braze, Inc. stock public?
Yes, Braze, Inc. is a publicly traded company.